| Sep 19 |
Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns
|
| Sep 13 |
Amphastar Pharmaceuticals Offers Interesting Growth And Income Prospects
|
| Sep 12 |
Amphastar: Perplexing Pipeline, Lumpy Revenues - I'm On Sidelines
|
| Aug 28 |
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
|
| Aug 9 |
Amphastar Pharmaceuticals, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 9 |
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2024 Earnings Call Transcript
|
| Aug 9 |
Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Aug 7 |
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
|
| Aug 7 |
Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates
|
| Aug 7 |
Amphastar Pharmaceuticals Non-GAAP EPS of $0.94 beats by $0.19, revenue of $182.39M beats by $11.48M
|
